In this episode, we are joined by Dr. Ralph J. Riello III, PharmD, BCPS, Clinical Pharmacy Specialist, Cardiorenal & Metabolism, Yale School of Medicine, and Dr. Nihar Desai, MD, MPH, Associate Professor, Yale School of Medicine, Vice Chief, Cardiovascular Medicine, to discuss the key findings from the PROMPT-Lipid Trial. The PROMPT-LIPID trial was designed to evaluate whether automated electronic alerts with guideline-based recommendations can help improve the management of hyperlipidemia among patients with established atherosclerotic cardiovascular disease at very high risk for cardiovascular events. This episode is sponsored by Amgen.
Summary
Improving Cardiovascular Disease Management with Automated Electronic Alerts: Key Findings from PROMPT-Lipid Trial
The PROMPT-LIPID trial evaluated the effectiveness of automated electronic alerts with guideline-based recommendations in managing hyperlipidemia among patients with established atherosclerotic cardiovascular disease at high risk for cardiovascular events. In this episode, Dr. Ralph J. Riello III, PharmD, BCPS, Clinical Pharmacy Specialist, Cardiorenal & Metabolism, Yale School of Medicine, and Dr. Nihar Desai, MD, MPH, Associate Professor, Yale School of Medicine, Vice Chief, Cardiovascular Medicine, share the key findings from the trial and how electronic health record (EHR) alerts can improve quality of care.
The Prompt Lipid Trial: Improving Quality of Care
Dr. Ralph Rlo and Dr. Nihar Desai found that healthcare providers who received decision alerts were 40% more likely to intensify lipid-lowering treatment. Among providers who interacted more favorably with the alerts, there was a twofold increase in the use of evidence-based lipid-lowering therapies. Dr. Rlo explained why this population was compelling to test an innovative approach to quality improvement. The trial's success can be attributed to the team's strategy of engaging with frontline cardiology stakeholders in the design process.
User-friendly and Effective Design
Alert fatigue is a pressing concern for clinicians, and the study addressed this barrier by making the alert look more user-friendly and embedding ordering capability within it. The team thoroughly evaluated the alert after it was deployed, and Dr. Desai discussed how their approach enabled favorable user findings.
The Way Forward: Expanding the Study and Exploring Findings
Now that the trial is completed, the team is looking to expand the study to other systems, EHR platforms, and clinical settings in order to further explore its findings. The use of EHR alerts can bridge the gap between publication of evidence-based guidelines and consistent implementation and practice by healthcare providers. This episode was sponsored by Amgen.
Conclusion
The PROMPT-LIPID trial demonstrated the potential of automated electronic alerts with guideline-based recommendations in improving the management of hyperlipidemia among patients at high risk for cardiovascular events. The success of the trial was attributed to user-friendly and effective design and engaging with frontline cardiology stakeholders in the design process.
Note: This is an AI generated transcript, not edited by a staff writer and is solely intended for educational purposes. If you have any questions/concerns, reach out to podcasts@beckershealthcare.com
This episode aired on 03/01/2023 and can be listened here.